chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bursitis, Injection site pain, Pain, Pain in extremity
Clinical narrative: normal pain at the injection site; same arm and that shoulder started hurting when I move certain ways; shoulder started hurting when I move certain ways; bursitis; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication included hydrochlorothiazide (MANUFACTURER UNKNOWN) and omeprazole (OMEPRAZOLE), both for unknown indications from unknown dates. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced normal pain at the injection site that went away after a couple days. A few days after that, the same arm and that shoulder started hurting when she moved certain ways. Her primary care MD examined her and diagnosed bursitis. The doctor said the shot likely nicked the bursa under the muscle. The events resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of events and included treatment with prescribed diclofenac gel for pain and inflammation. The clinical outcome of the event pain at the injection site was recovered after a couple days on 29Mar2021 and the outcome of the events same arm and that shoulder started hurting when she moved certain ways and bursitis were not resolved at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bursitis, Pain in extremity, Vaccination site pain
Clinical narrative: normal pain at the injection site; same arm and that shoulder started hurting when I move certain ways; shoulder started hurting when I move certain ways; bursitis; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication included hydrochlorothiazide (MANUFACTURER UNKNOWN) and omeprazole (OMEPRAZOLE), both for unknown indications from unknown dates. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced normal pain at the injection site that went away after a couple days. A few days after that, the same arm and that shoulder started hurting when she moved certain ways. Her primary care MD examined her and diagnosed bursitis. The doctor said the shot likely nicked the bursa under the muscle. The events resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of events and included treatment with prescribed diclofenac gel for pain and inflammation. The clinical outcome of the event pain at the injection site was recovered after a couple days on 29Mar2021 and the outcome of the events same arm and that shoulder started hurting when she moved certain ways and bursitis were not resolved at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Severe rash; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8731), via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medication within two weeks of vaccination. The patient previously took diclofenac (MANUFACTURER UNKOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 09:00, the patient experienced severe rash. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe rash was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Eye irritation, Fatigue, Pallor
Clinical narrative: Eyes started burning; Chills(fever); Tired; No energy; looked pale; smelling an odor like garbage; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulosis. The patient had no allergies to medications, food, or other products. Concomitant medications included paracetamol (ACETAMINOPHEN) and monascus purpureus (RED YEAST RICE), both taken from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 (Saturday) at 00:30, the patient took 2 acetaminophen which he takes at night and at 06:30, the patient experienced chills(fever) which had lasted for a couple of hours, tired, no energy, had no food until dinner time and looked pale. On the same day afternoon, the patient smelled an odor like garbage but his wife said she did not smell anything and it lasted for a few hours. On 04Apr2021 (Sunday), his energy was still low and his eyes started burning. It was reported that the patient rinsed his eyes with saline solution every morning for the past 20 years, he had skipped it on 03Apr2021 and while rinsing his eyes on 04Apr2021, his eyes started burning for which he tried a different bottle, but it was still burning and he had to stop. On 05Apr2021 (Monday), the patient felt better and rinsed his eyes with no problem. He reported that he never had smell and eye problem before. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills(fever) and smelled an odor like garbage was resolved on 03Apr2021, burning eyes was resolved on 05Apr2021 and tired, no energy, and looked pale were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Parosmia, Pyrexia
Clinical narrative: Eyes started burning; Chills(fever); Tired; No energy; looked pale; smelling an odor like garbage; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulosis. The patient had no allergies to medications, food, or other products. Concomitant medications included paracetamol (ACETAMINOPHEN) and monascus purpureus (RED YEAST RICE), both taken from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 (Saturday) at 00:30, the patient took 2 acetaminophen which he takes at night and at 06:30, the patient experienced chills(fever) which had lasted for a couple of hours, tired, no energy, had no food until dinner time and looked pale. On the same day afternoon, the patient smelled an odor like garbage but his wife said she did not smell anything and it lasted for a few hours. On 04Apr2021 (Sunday), his energy was still low and his eyes started burning. It was reported that the patient rinsed his eyes with saline solution every morning for the past 20 years, he had skipped it on 03Apr2021 and while rinsing his eyes on 04Apr2021, his eyes started burning for which he tried a different bottle, but it was still burning and he had to stop. On 05Apr2021 (Monday), the patient felt better and rinsed his eyes with no problem. He reported that he never had smell and eye problem before. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills(fever) and smelled an odor like garbage was resolved on 03Apr2021, burning eyes was resolved on 05Apr2021 and tired, no energy, and looked pale were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Eye irritation, Fatigue, Pallor, Parosmia
Clinical narrative: Eyes started burning; Chills(fever); Tired; No energy; looked pale; smelling an odor like garbage; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulosis. The patient had no allergies to medications, food, or other products. Concomitant medications included paracetamol (ACETAMINOPHEN) and monascus purpureus (RED YEAST RICE), both taken from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 (Saturday) at 00:30, the patient took 2 acetaminophen which he takes at night and at 06:30, the patient experienced chills(fever) which had lasted for a couple of hours, tired, no energy, had no food until dinner time and looked pale. On the same day afternoon, the patient smelled an odor like garbage but his wife said she did not smell anything and it lasted for a few hours. On 04Apr2021 (Sunday), his energy was still low and his eyes started burning. It was reported that the patient rinsed his eyes with saline solution every morning for the past 20 years, he had skipped it on 03Apr2021 and while rinsing his eyes on 04Apr2021, his eyes started burning for which he tried a different bottle, but it was still burning and he had to stop. On 05Apr2021 (Monday), the patient felt better and rinsed his eyes with no problem. He reported that he never had smell and eye problem before. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills(fever) and smelled an odor like garbage was resolved on 03Apr2021, burning eyes was resolved on 05Apr2021 and tired, no energy, and looked pale were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Eyes started burning; Chills(fever); Tired; No energy; looked pale; smelling an odor like garbage; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulosis. The patient had no allergies to medications, food, or other products. Concomitant medications included paracetamol (ACETAMINOPHEN) and monascus purpureus (RED YEAST RICE), both taken from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 12Mar2021 at 15:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 (Saturday) at 00:30, the patient took 2 acetaminophen which he takes at night and at 06:30, the patient experienced chills(fever) which had lasted for a couple of hours, tired, no energy, had no food until dinner time and looked pale. On the same day afternoon, the patient smelled an odor like garbage but his wife said she did not smell anything and it lasted for a few hours. On 04Apr2021 (Sunday), his energy was still low and his eyes started burning. It was reported that the patient rinsed his eyes with saline solution every morning for the past 20 years, he had skipped it on 03Apr2021 and while rinsing his eyes on 04Apr2021, his eyes started burning for which he tried a different bottle, but it was still burning and he had to stop. On 05Apr2021 (Monday), the patient felt better and rinsed his eyes with no problem. He reported that he never had smell and eye problem before. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills(fever) and smelled an odor like garbage was resolved on 03Apr2021, burning eyes was resolved on 05Apr2021 and tired, no energy, and looked pale were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest pain
Clinical narrative: Severe/sharp chest pain; Back pain; Discomfort; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Mar2021 at 11:00 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks prior to the vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, after about 6 or 7 days of receiving the Pfizer vaccine the patient experienced severe/sharp chest pain and back pain and discomfort, that lasted and decreased after several days until after about 3 weeks the pain and discomfort was gone. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe/sharp chest pain and back pain and discomfort were recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest pain, Discomfort
Clinical narrative: Severe/sharp chest pain; Back pain; Discomfort; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Mar2021 at 11:00 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks prior to the vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Mar2021, after about 6 or 7 days of receiving the Pfizer vaccine the patient experienced severe/sharp chest pain and back pain and discomfort, that lasted and decreased after several days until after about 3 weeks the pain and discomfort was gone. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe/sharp chest pain and back pain and discomfort were recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Discomfort, Erythema, Heart rate increased, Hypoaesthesia
Clinical narrative: Feel exhausted and itchy; Feel exhausted and itchy; heart rate can accelerate erratically, but no where near as high as at the peak of the reaction; Hives, red and swollen face; Hives, red and swollen face; Hives, red and swollen face; Numb right hand; Swollen mouth; Rapid heart rate; Anxiety/fear; Anxiety/fear; Itchy throat; Feeling terrible and uncomfortable in body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 729) via an unspecified route of administration in the arm right on 10Apr2021 at 17:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical. Concomitant medications included acetylsalicylic acid (ASPIRIN and calcium ascorbate (VIT C); both on an unknown date for unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:45, the patient experienced Hives, red and swollen face, numb right hand, swollen mouth, rapid heart rate, anxiety/fear, itchy throat, feeling terrible and uncomfortable in body. Peak of reaction was over by 3.5 hours post injection. Heart beat calmed 5 hours post injection. On 11Apr2021, the patient experienced Feel exhausted and itchy today, heart rate can accelerate erratically, but nowhere near as high as at the peak of the reaction. On an unknown date in Mar2020, the patient underwent COVID test and the result was Positive (was presumed Covid-19 positive in March 2020). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event rapid heart rate was recovered on 10Apr2021 and of the Hives, red face, swollen face, numb right hand, swollen mouth, anxiety, fear, itchy throat, feeling terrible and uncomfortable in body, feel exhausted and itchy and heart rate can accelerate erratically was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Muscle tightness, Musculoskeletal stiffness, Pharyngeal erythema, Pharyngeal swelling
Clinical narrative: Feel exhausted and itchy; Feel exhausted and itchy; heart rate can accelerate erratically, but no where near as high as at the peak of the reaction; Hives, red and swollen face; Hives, red and swollen face; Hives, red and swollen face; Numb right hand; Swollen mouth; Rapid heart rate; Anxiety/fear; Anxiety/fear; Itchy throat; Feeling terrible and uncomfortable in body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 729) via an unspecified route of administration in the arm right on 10Apr2021 at 17:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical. Concomitant medications included acetylsalicylic acid (ASPIRIN and calcium ascorbate (VIT C); both on an unknown date for unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:45, the patient experienced Hives, red and swollen face, numb right hand, swollen mouth, rapid heart rate, anxiety/fear, itchy throat, feeling terrible and uncomfortable in body. Peak of reaction was over by 3.5 hours post injection. Heart beat calmed 5 hours post injection. On 11Apr2021, the patient experienced Feel exhausted and itchy today, heart rate can accelerate erratically, but nowhere near as high as at the peak of the reaction. On an unknown date in Mar2020, the patient underwent COVID test and the result was Positive (was presumed Covid-19 positive in March 2020). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event rapid heart rate was recovered on 10Apr2021 and of the Hives, red face, swollen face, numb right hand, swollen mouth, anxiety, fear, itchy throat, feeling terrible and uncomfortable in body, feel exhausted and itchy and heart rate can accelerate erratically was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Urticaria
Clinical narrative: Feel exhausted and itchy; Feel exhausted and itchy; heart rate can accelerate erratically, but no where near as high as at the peak of the reaction; Hives, red and swollen face; Hives, red and swollen face; Hives, red and swollen face; Numb right hand; Swollen mouth; Rapid heart rate; Anxiety/fear; Anxiety/fear; Itchy throat; Feeling terrible and uncomfortable in body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 729) via an unspecified route of administration in the arm right on 10Apr2021 at 17:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical. Concomitant medications included acetylsalicylic acid (ASPIRIN and calcium ascorbate (VIT C); both on an unknown date for unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:45, the patient experienced Hives, red and swollen face, numb right hand, swollen mouth, rapid heart rate, anxiety/fear, itchy throat, feeling terrible and uncomfortable in body. Peak of reaction was over by 3.5 hours post injection. Heart beat calmed 5 hours post injection. On 11Apr2021, the patient experienced Feel exhausted and itchy today, heart rate can accelerate erratically, but nowhere near as high as at the peak of the reaction. On an unknown date in Mar2020, the patient underwent COVID test and the result was Positive (was presumed Covid-19 positive in March 2020). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event rapid heart rate was recovered on 10Apr2021 and of the Hives, red face, swollen face, numb right hand, swollen mouth, anxiety, fear, itchy throat, feeling terrible and uncomfortable in body, feel exhausted and itchy and heart rate can accelerate erratically was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Erythema, Fatigue, Fear, Feeling abnormal
Clinical narrative: Feel exhausted and itchy; Feel exhausted and itchy; heart rate can accelerate erratically, but no where near as high as at the peak of the reaction; Hives, red and swollen face; Hives, red and swollen face; Hives, red and swollen face; Numb right hand; Swollen mouth; Rapid heart rate; Anxiety/fear; Anxiety/fear; Itchy throat; Feeling terrible and uncomfortable in body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 729) via an unspecified route of administration in the arm right on 10Apr2021 at 17:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical. Concomitant medications included acetylsalicylic acid (ASPIRIN and calcium ascorbate (VIT C); both on an unknown date for unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:45, the patient experienced Hives, red and swollen face, numb right hand, swollen mouth, rapid heart rate, anxiety/fear, itchy throat, feeling terrible and uncomfortable in body. Peak of reaction was over by 3.5 hours post injection. Heart beat calmed 5 hours post injection. On 11Apr2021, the patient experienced Feel exhausted and itchy today, heart rate can accelerate erratically, but nowhere near as high as at the peak of the reaction. On an unknown date in Mar2020, the patient underwent COVID test and the result was Positive (was presumed Covid-19 positive in March 2020). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event rapid heart rate was recovered on 10Apr2021 and of the Hives, red face, swollen face, numb right hand, swollen mouth, anxiety, fear, itchy throat, feeling terrible and uncomfortable in body, feel exhausted and itchy and heart rate can accelerate erratically was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypoaesthesia, Mouth swelling, Pruritus, SARS-CoV-2 test
Clinical narrative: Feel exhausted and itchy; Feel exhausted and itchy; heart rate can accelerate erratically, but no where near as high as at the peak of the reaction; Hives, red and swollen face; Hives, red and swollen face; Hives, red and swollen face; Numb right hand; Swollen mouth; Rapid heart rate; Anxiety/fear; Anxiety/fear; Itchy throat; Feeling terrible and uncomfortable in body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 729) via an unspecified route of administration in the arm right on 10Apr2021 at 17:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical. Concomitant medications included acetylsalicylic acid (ASPIRIN and calcium ascorbate (VIT C); both on an unknown date for unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:45, the patient experienced Hives, red and swollen face, numb right hand, swollen mouth, rapid heart rate, anxiety/fear, itchy throat, feeling terrible and uncomfortable in body. Peak of reaction was over by 3.5 hours post injection. Heart beat calmed 5 hours post injection. On 11Apr2021, the patient experienced Feel exhausted and itchy today, heart rate can accelerate erratically, but nowhere near as high as at the peak of the reaction. On an unknown date in Mar2020, the patient underwent COVID test and the result was Positive (was presumed Covid-19 positive in March 2020). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event rapid heart rate was recovered on 10Apr2021 and of the Hives, red face, swollen face, numb right hand, swollen mouth, anxiety, fear, itchy throat, feeling terrible and uncomfortable in body, feel exhausted and itchy and heart rate can accelerate erratically was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Throat irritation, Urticaria
Clinical narrative: Feel exhausted and itchy; Feel exhausted and itchy; heart rate can accelerate erratically, but no where near as high as at the peak of the reaction; Hives, red and swollen face; Hives, red and swollen face; Hives, red and swollen face; Numb right hand; Swollen mouth; Rapid heart rate; Anxiety/fear; Anxiety/fear; Itchy throat; Feeling terrible and uncomfortable in body; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 729) via an unspecified route of administration in the arm right on 10Apr2021 at 17:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no medical. Concomitant medications included acetylsalicylic acid (ASPIRIN and calcium ascorbate (VIT C); both on an unknown date for unknown indication. The patient had no known allergies to medications, food or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:45, the patient experienced Hives, red and swollen face, numb right hand, swollen mouth, rapid heart rate, anxiety/fear, itchy throat, feeling terrible and uncomfortable in body. Peak of reaction was over by 3.5 hours post injection. Heart beat calmed 5 hours post injection. On 11Apr2021, the patient experienced Feel exhausted and itchy today, heart rate can accelerate erratically, but nowhere near as high as at the peak of the reaction. On an unknown date in Mar2020, the patient underwent COVID test and the result was Positive (was presumed Covid-19 positive in March 2020). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event rapid heart rate was recovered on 10Apr2021 and of the Hives, red face, swollen face, numb right hand, swollen mouth, anxiety, fear, itchy throat, feeling terrible and uncomfortable in body, feel exhausted and itchy and heart rate can accelerate erratically was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Vasoconstriction
Clinical narrative: Numbness and blood withdrawal on toes of my left foot when exposed to mild cold weather; blood withdrawal on toes of left foot when exposed to mild cold weather; This is a raynaud's like syndrome I have never experienced prior to getting the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 22Mar2021 at 08:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergy to any medications, food, or other products. The patient did not receive any concomitant medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 12:00 the patient experienced numbness and blood withdrawal on toes of left foot when exposed to mild cold weather. It started with just a part of his big toe and then spread to all toes on the left foot. The patient's right foot was perfectly normal. This was a Raynaud's like syndrome and never experienced by the patient prior to getting the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events numbness, blood withdrawal on toes of the left foot when exposed to mild cold weather and Raynaud's like syndrome were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Peripheral coldness, Raynaud's phenomenon
Clinical narrative: Numbness and blood withdrawal on toes of my left foot when exposed to mild cold weather; blood withdrawal on toes of left foot when exposed to mild cold weather; This is a raynaud's like syndrome I have never experienced prior to getting the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 22Mar2021 at 08:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergy to any medications, food, or other products. The patient did not receive any concomitant medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 12:00 the patient experienced numbness and blood withdrawal on toes of left foot when exposed to mild cold weather. It started with just a part of his big toe and then spread to all toes on the left foot. The patient's right foot was perfectly normal. This was a Raynaud's like syndrome and never experienced by the patient prior to getting the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events numbness, blood withdrawal on toes of the left foot when exposed to mild cold weather and Raynaud's like syndrome were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dysgeusia, Fatigue, Headache, Myalgia
Clinical narrative: Dizziness; Fatigue; Metallic taste in mouth; Soreness; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included linum usitatissimum seed oil (FLAXSEED OIL); on an unknown date for unknown indication. The patient previously took Zithromax and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 08:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:30, the patient experienced dizziness, fatigue, soreness and metallic taste in mouth. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness, fatigue, soreness and metallic taste in mouth were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Taste disorder
Clinical narrative: Dizziness; Fatigue; Metallic taste in mouth; Soreness; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included linum usitatissimum seed oil (FLAXSEED OIL); on an unknown date for unknown indication. The patient previously took Zithromax and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 08:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:30, the patient experienced dizziness, fatigue, soreness and metallic taste in mouth. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness, fatigue, soreness and metallic taste in mouth were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dysgeusia, Fatigue, Pain
Clinical narrative: Dizziness; Fatigue; Metallic taste in mouth; Soreness; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included linum usitatissimum seed oil (FLAXSEED OIL); on an unknown date for unknown indication. The patient previously took Zithromax and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 08:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:30, the patient experienced dizziness, fatigue, soreness and metallic taste in mouth. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness, fatigue, soreness and metallic taste in mouth were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: pins and needles; Tingling in extremities; This is a spontaneous report from a contactable other healthcare professional, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 11:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 21:00, the patient experienced pins and needles and tingling in extremities. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pins and needles and tingling in extremity was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: pins and needles; Tingling in extremities; This is a spontaneous report from a contactable other healthcare professional, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 11:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 21:00, the patient experienced pins and needles and tingling in extremities. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pins and needles and tingling in extremity was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Infection
Clinical narrative: Recurrent gentian herpes outbreak;This is a spontaneous report from a contactable consumer, the patient. A 25-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ethinylestradiol, norgestimate (TRINESSA LO) from an unknown date for birth control, spironolactone (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. It was unknown if the patient was pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 15:00, the patient experienced recurrent gentian herpes outbreak. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event Recurrent gentian herpes outbreak was resolving.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.